Vicore Pharma to Participate in the DNB Carnegie Nordic Healthcare Conference
Vicore Pharma announced its participation in the upcoming DNB Carnegie Nordic Healthcare Conference in Oslo, Norway.
Stocks · News reference
Jefferies analyst Faisal Khurshid initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $25.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Vicore Pharma announced its participation in the upcoming DNB Carnegie Nordic Healthcare Conference in Oslo, Norway.
Vicore Pharma announced its participation in the upcoming Jefferies Global Healthcare Conference in London, where the company will conduct a fireside chat and one-on-one meetings.
Investment firm Chardan has initiated coverage on Vicore Pharma Holding AB with a 'Buy' rating and a $15 price target.
Vicore Pharma reported its financial results for the third quarter ended September 30, 2026, and provided an update on its clinical programs, including the ASPIRE study.
Vicore Pharma Holding AB has announced the composition of its Nomination Committee for the 2027 Annual General Meeting, based on the holdings of its three largest shareholders as of August 31, 2026.
Vicore Pharma Holding AB announced its participation in the Guggenheim 3rd Annual Healthcare Innovation Conference and the Stifel 2026 Healthcare Conference in November 2026.